Lv2
140 积分 2022-11-22 加入
TERT Promoter Mutations Are a Major Indicator of Poor Outcome in Differentiated Thyroid Carcinomas
13天前
已完结
TERTPromoter Mutations and Their Association withBRAFV600E Mutation and Aggressive Clinicopathological Characteristics of Thyroid Cancer
13天前
已完结
Genetic analysis and clinicopathologic features of locally advanced papillary thyroid cancers: a prospective observational study
14天前
已完结
A Significance of Concomitant BRAFV600E and TERT Mutations in Polish Patients with Papillary Thyroid Microcarcinoma: A Retrospective Cohort Study Based on 430 Cases
17天前
已完结
A Combination of BRAF and EZH1/SPOP/ZNF148 Three-Gene Mutational Classifier Improves Benign Call Rate in Indeterminate Thyroid Nodules
18天前
已完结
Neoadjuvant Treatment of Locally Advanced Thyroid Cancer: A Preliminary Latin American Experience
21天前
已完结
Characterization of the Thyroid Cancer Genomic Landscape by Plasma-Based Circulating Tumor DNA Next-Generation Sequencing
1个月前
已完结
Wnt/B-catenin activation and TP53 mutations associate with distinct immune profiles in advanced thyroid cancer
1个月前
已完结
Oncogenic mutations in the TP53 and PI-3 kinase/AKT pathway are independent predictors of survival for advanced thyroid cancer: Analysis from the Molecular Screening and Therapeutics (MoST) program
1个月前
已完结
Brusatol attenuated proliferation and invasion induced by KRAS in differentiated thyroid cancer through inhibiting Nrf2
1个月前
已完结
皖公网安备34019202002308
